|
Hypothesis testing_ |
1 |
|
Power and sample size |
88-89 |
|
Endpoints of treatment effect |
160-161 |
|
Clinical trials in RO |
266-267 |
|
Comparing technologies |
362-363 |
|
Meta-analysis |
478-479 |
|
Parameter estimation |
572-573 |
|
Dose response |
664-665 |
|
Infrastructure for clin. rad. research |
766-767 |
|
Models in clinical practice |
884-885 |
|
NTCP |
984-985 |
|
Sensitivity specificity |
1090-1091 |
|
Risks Clinical Epidemiology |
1166-1167 |
|
Decision support system |
1236-1237 |
|
Competing risks & health state data |
1346-1347 |
|
Imaging endpoints |
1406-1407 |
|
Radiomics |
1514-1515 |
|
Data presentation |
1604-1605 |


